Aims To evaluate how recommendations of European guidelines regarding
pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in …

Background Recent registries have shown that recommended drugs for the treatment of
chronic heart failure (CHF) are under‐prescribed in daily practice. Aims To determine …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Objectives This study evaluated the impact of clinical and physiological factors limiting
treatment optimization toward recommended medical therapy in heart failure (HF) …

Objectives: This study investigated adherence to drug therapy guidelines in heart failure
(HF) with reduced left-ventricular ejection fraction (LVEF) of< 40%(heart failure with reduced …

Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in
2006, much has changed in the care for patients with HF. Over the past decade, the HF …

Aims Surveys on heart failure management suggest under-utilization of life-saving evidence-
based treatment. Evidence-based medicine and clinical guidelines are based on the results …

Background Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor
blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of …

Aims Patients with heart failure (HF) randomized in controlled trials are generally selected
and do not fully represent the 'real world'. The purpose of this study is to better describe the …

The aim of this report is to provide practical guidelines for the diagnosis, assessment and
treatment of heart failure for use in clinical practice and in addition for epidemiological …